-
1
Topical Administration of a Nanoformulation of Chitosan-Hyaluronic Acid-Epoetin Beta in a Rat Model of Glaucoma
Published 2023-01-01Subjects: Get full text
Article -
2
Chitosan and Hyaluronic Acid Nanoparticles as Vehicles of Epoetin Beta for Subconjunctival Ocular Delivery
Published 2022-02-01Subjects: Get full text
Article -
3
SELECTION OF THERAPEUTIC TACTICS FOR EARLY ANEMIA OF PREMATURE INFANTS WITH VERY LOW OR EXTREMELY LOW BIRTH WEIGHT: RETROSPECTIVE STUDY RESULTS
Published 2016-02-01Subjects: Get full text
Article -
4
The resistance to methoxy polyethylene glycol-epoetin beta in anemic patients of end-stage renal disease
Published 2023-02-01Subjects: “…Methoxy polyethylene glycol-epoetin beta…”
Get full text
Article -
5
-
6
Association of I/D angiotensin-converting enzyme genotype with erythropoietin stimulation in kidney failure
Published 2017-01-01Subjects: Get full text
Article -
7
Comparative pharmacoeconomic analysis of the use of erythropoiesis-stimulating drugs for the treatment of anemia in cancer patients
Published 2021-12-01Subjects: Get full text
Article -
8
Long-term safety and effectiveness of a continuous erythropoietin receptor activator (CERA) in patients with renal anemia: a prospective, observational, multicenter study
Published 2019-06-01Subjects: “…Methoxy polyethylene glycol-epoetin beta…”
Get full text
Article -
9
Antibody-mediated pure red cell aplasia related with epoetin-beta pegol (C.E.R.A.) as an erythropoietic agent: case report of a dialysis patient
Published 2020-07-01Subjects: Get full text
Article -
10
Epoetin beta pegol for treatment of anemia ameliorates deterioration of erythrocyte quality associated with chronic kidney disease
Published 2018-01-01Subjects: “…Epoetin beta pegol (C.E.R.A.)…”
Get full text
Article